Microcrystallization of indomethacin using a pH-shift method

International Journal of Pharmaceutics

Volumn 263, Issue 1-2, 2003, Pages 141-150

  Kim, Sung Tae ^a   Kwon, Jai Hyun ^a   Lee, Jae Jeong ^a   Kim, Chan Wha ^a  

^a Korea University   (South Korea)

Author keywords

HT 29; Indomethacin; Microcrystallization; pH shift

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

AQUEOUS SOLUTION; ARTICLE; CANCER CELL; COLORECTAL CANCER; CONTROLLED STUDY; CRYSTAL; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ACTIVITY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MELTING POINT; PHASE CONTRAST MICROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 0042884302     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00358-2     Document Type: Article

References (15)

1. Budavari, S., 1996. The Merk Index, 20th ed. Merk & Co. Inc., NJ, USA.
2. Dannhardt G., Kiefer W. Cyclooxygenase inhibitor-current status and future prospects. Eur. J. Med. Chem. 36:2001;109-126.
3. Ducruix, A., Giege, R., 1999. Crystallization of Nucleic Acids and Proteins. Oxford University Press, New York.
4. Fessenden, R.J., Fessenden, J.S., Logue, M.W., 1998. Session 9.4. The Infrared Spectrum, Organic Chemistry - Fessenden Fessenden, sixth ed. Brooks/Cole Publishing Company, New York.
5. Gabr K.E. Influence of indomethacin-mastic combinations on dissolution, absorption and gastrointestinal mucosal damage in rats. Int. J. Pharm. 158:1997;137-145.
6. Gibson, M., 2001. Pharmaceutical Preformulation and Formulation - A Practical Guide from Candidate Drug Selection to Commercial Dosage Form. HIS Health Group, Englewood.
7. Kubba A.K. Nonsteroidal anti-inflammatory drugs and colorectal cancer: is there a way forward? Eur. J. Cancer. 35:1999;892-901.
8. Lim S., Lee K.Y., Lee M.S., Choi C.N., Kim Y.D. Controlled release of indomethacin using biodegradable polymer microspheres. Korean J. Biotech. Bioeng. 16:2001;505-510.
9. Longuemard P., Jbilou M., Guyot-Hermann A.M., Guyot J.C. Ground and native crystals: comparison of compression capacity and dissolution rate. Int. J. Pharm. 170:1998;51-61.
10. Orienti I., Bigucci F., Luppi B., Cerchiara T., Zuccari G., Giunchedi P., Zecchi V. Polyvinylalcohol substituted with triethyleneglycolmonoethylether as a new material for preparation of solid dispersion of hydrophobic drugs. Eur. J. Pharm. Biopharm. 54:2002;229-233.
11. Sarkari M., Brown J., Chen X., Swinnea S., William R.O., Johnston K.P. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 243:2002;17-31.
12. Singla A.K., Wadhwa H. Zinc-indoemthacin complex: synthesis, physicochemical and biological evaluation in the rat. Int. J. Pharm. 120:1995;145-155.
13. Smith M.L., Hawcroft G., Hull M.A. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur. J. Cancer. 36:2000;664-674.
14. Thun M.J. Aspirin, NSAIDs and digestive tract cancers. Cancer Metastasis Rev. 13:1994;269-277.
15. Ying R.M., Turner P., Kennedy B.J., Hambley T.W., Lay P.A., Briffin J.R., Regtop H.L., Waraick B. Preparation and characterization of dinuclear copper-indomethacin anti-inflammatorydrugs. Inorg. Chem. Acta. 324:2001;150-161.